Tobramycin Sulfate S715 solid lipid nanoparticle (SLN)

solid lipid nanoparticle (SLN)

Sequence position 2027-2028: Missing T (Position 1893 in Genbank)

Protease-free formulation: Suitable for sensitive protein-based applications without proteolytic degradation risk

It primarily serves as a carbon source for yeast as well as being an important component in some cryopreservation solutions

Tobramycin Sulfate S715 solid lipid nanoparticle (SLN)Tobramycin is an aminoglycoside antibiotic isolated from Streptomyces tenebrarius targeting gram negative bacteria. It is often used to combat Pseudomonas species. It has been used to study cystic fibrosis and a variety of respiratory infections. Tobramycin sulfate is freely soluble in aqueous solution. Aminoglycoside antibiotics are composed of amino groups attached to glycosides. They bind the 30s ribosomal subunit, causing misreading of the mRNA